FDA Inspection 1311388 — Upstate New York Transplant Services, Inc.
The FDA completed an inspection of Upstate New York Transplant Services, Inc. on March 19, 2026 in Tonawanda, NY. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 19, 2026
- Fiscal Year
- 2026
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Tonawanda, NY (United States)